Barbara Ryan

Filings by Barbara Ryan span 4 companies, the busiest being MiNK Therapeutics, Inc., Indivior Pharmaceuticals, Inc. and INVO Fertility, Inc. In total, 23 filings cover trades dated from 15 January 2022 to 13 May 2026.

The open-market side counts 4 purchases for €34k alongside 2 sales for €5,445. Taken together, the purchases exceed the sales by €28k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 17 share grants. 2026 to date brings 3 purchases and 2 sales.

A typical purchase (the median) is worth €5,131. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 14 May 2026 with a share grant in Indivior Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 219 days ago, on 13 March 2026. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.